Germany Oncology Drugs Market Analysis


  • Type: Therapeutics Area
  • Published : February 2022
  • Region: Europe
  • Country: Germany
  • Report ID : 5070

  • Format: PPT, PDF

Germany Oncology Drugs Market: Segmented by Cancer Type, Treatment Type,and End User Type – Growth, Market Size, Future Prospects & Competitive Analysis, 2021 – 2028

SKU: 5070 Categories: ,

Report Description of the Germany Oncology Drugs Market

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Research Objective:

  • To analyze and forecast the market size of Germany Oncology Drugs Drugs market
  • To classify and forecast Germany Oncology Drugs Market market based on application, drugs, project type, and application.
  • To identify drivers and challenges for Germany Oncology Drugs market
  • To examine competitive developments such as mergers and acquisitions, agreements, collaborations and partnerships, etc., in Germany Oncology Drugs market
  • To conduct pricing analysis for Germany Oncology Drugs Drugs market
  • To identify and analyze the profile of leading players operating in Germany Oncology Drugs market

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for Atopic Dermatitis drug market
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the Atopic Dermatitis market
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy-based consulting analysis

Germany Oncology Drugs Market Executive Summary

In Germany, nearly a quarter of men and 20% of women die of cancer, and it is estimated that in Germany around 51% men and 43% women will develop cancer during lifetime, consequently leading to the growth of the market. The cancer diagnostics and profiling markets are growing, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease

Market Size and Key Findings

The Germany Oncology Drugs market size is at around USD xx billion in 2021 and is projected to reach USD xx billion in 2028, exhibiting a CAGR of xx% during the forecast period.

In Germany the cancer incidence case number as well as the number of deaths for the most common cancers in the German population for the years 2020 and 2030. By 2030, Breast Cancer cases (69,697) were seen to be the highest gaining 11% of the total cases observed in Germany followed by Prostate (67,959) and Lung Cancer (64,804) in the total cases (333,384) observed in 2020.

Market Dynamics

Market Growth Drivers Analysis

The driving factors for the growth of the cancer therapeutics market in Germany includes, ease in regulatory approval, increased healthcare spending for cancer, rising prevalence of cancer, strong R&D initiatives from key players.The direct cost of cancer has also increased, and thus, the cost of cancer drugs as a share of direct health costs has doubled. The increase in the cost of cancer treatment, along with drug prices, has resulted in the growth of the overall market. In addition, the heavy investments made in R&D activities have enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and a surge in cancer prevalence have boosted the market growth.

Market Restraints

Inequality in access of cancer therapy and high Cost of Cancer Therapies associated with the oncology drugs are negatively influencing the growth of the market.

COVID-19 impact on “Germany Oncology Drugs Market” 

The outbreak of COVID-19 has had a positive impact on the oncology drugs market globally. Certain market segments have witnessed a growth in demand for drugs with respect to the COVID-19 emergency. Panic buying of medications has been witnessed among the cancer patients amid lockdown

Competitive Landscape

Key Players

With an exceedingly competitive market comprising more than 40 companies, some of the renowned players are QIAGEN N.V., Abbott, Agilent Technologies, Applied Gene Technologies, Arca Biopharma, Beckman Coulter/Danaher, Becton Dickinsons and Others.

Products in Pipeline

Boehringer Ingelheim today announced the advancement of the bi-specific and tetravalent therapeutic antibody, BI 905711, to its first-in-human clinical trial for patients with advanced gastrointestinal (GI) cancers. The first-in-class BI 905711 antibody is designed to recognize both the pro-apoptotic tumor necrosis factor (TNF)-related apoptosis-inducing ligand receptor 2 (TRAILR2) and the tumor cell anchor cadherin 17 (CDH17) to activate the self-destruction (apoptosis) pathway in co-expressing tumor cells found mostly in the GI tract.

BI 905711is  into Phase 1 clinical trials as we continue to grow oncology pipeline to transform patients’ lives. This bispecific platform has the potential to target complex mechanisms that may not be accessible with traditional antibody formats.

Notable Recent Deals

Boehringer Ingelheim and Lupin Limited (Lupin) today announced a licensing, development and commercialization agreement for Lupin’s MEK inhibitor compound (LNP3794) as a potential targeted therapy for patients with difficult-to-treat cancers. The partnership aims to develop Lupin’s lead MEK inhibitor compound in combination with one of Boehringer Ingelheim’s innovative KRAS inhibitors for patients with gastrointestinal and lung cancers harboring a broad range of oncogenic KRAS mutations.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario of Germany Oncology Drugs Services

Prices for cancer drugs, especially newly developed drugs are rising significantly. In Germany, for example, Dr. Lauterbach estimates that from now to 2030, within only 15 years, expenditure on cancer drugs will increase from about 6 billion Euros per year to possibly 40 billion Euros per year.

1. Report Description of the Germany Oncology Drugs Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Germany Oncology Drugs Market Executive Summary
2.1 Germany Oncology Drugs Market – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of Germany Oncology Drugs Market
3.1 Market Growth Drivers Analysis
3.1.1 Ease in regulatory approval
3.1.2 Increased healthcare spending for cancer
3.1.3 Rising prevalence of cancer
3.1.4 Strong R&D initiatives from key players
3.2 Market Restraints Analysis
3.3 Inequality in Access of Cancer Therapy
3.4 High Cost of Cancer Therapies
3.5 Covid-19 Market Impact Analysis
3.3.1 Positive impact on outcomes
4. Oncology Drugs Market Segmentation
4.1 By Cancer Type Analysis:
4.1.1 Breast cancer
4.1.2 Lung cancer
4.1.3 Colorectal cancer
4.1.4 Ovarian cancer
4.1.5 Blood Cancer
4.1.6 Prostate Cancer
4.1.7 Gastrointestinal Cancer
4.1.8 Gynecologic Cancer
4.1.9 Others
4.2 By Treatment Type Analysis:
4.2.1 Chemotherapy
4.2.2 Target Therapy
4.2.3 Immunotherapy (Biologic Therapy)
4.2.4 Hormonal Therapy
4.3 By End User Type Analysis:
4.3.1 Hospitals
4.3.2 Specialty Clinics
4.3.3 Cancer and Radiation Therapy Centres
5. Germany Oncology Drugs Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Germany Oncology Drugs Market
6.4 Notable recent deals in Germany Oncology Drugs Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers &Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles.
7.1 QIAGEN N.V Company Overview
Product & Services, Strategies & Financials
7.2 Abbott Company Overview
Product & Services, Strategies & Financials
7.3 Agilent Technologies Company Overview
Product & Services, Strategies & Financials
7.4 Applied Gene Technologies Company Overview
Product & Services, Strategies & Financials
7.5 Arca Biopharma Company Overview
Product & Services, Strategies & Financials
7.6 Beckman Coulter/Danaher Company Overview
Product & Services, Strategies & Financials
7.7 Becton Dickinsons Company Overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Pricing and Reimbursement scenario of Germany Oncology Drugs Market
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development Germany Oncology Drugs Market
9.2 Future Opportunities
10. Strategic Recommendations

Oncology Drugs Market Segmentation

By Cancer Type:

Breast cancer is the most prevalent cancer in the region, and the increasing incidence of this cancer and effective treatment of the targeted therapy in breast cancer patients are boosting the segment growth.

The cancer therapeutics market can be segmented based on the type of cancer as:

  • Breast cancer
  • Lung cancer
  • Colorectal cancer
  • Ovarian cancer
  • Blood Cancer
  • Prostate Cancer
  • Gastrointestinal Cancer
  • Gynecologic Cancer
  • Others

By Treatment Type:

Targeted therapy is also gaining traction due to its specificity toward cancer cells while sparing the toxicity to off-target cells.

Based on the type of treatment specified, the market is further segmented into:

  • Chemotherapy
  • Target Therapy
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy

By End User Type:

In lines with the global scenario, the German oncology market can also be segmented based on end-users as

  • Hospitals
  • Specialty Clinics
  • Cancer and Radiation Therapy Centres

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements